Psychopharmacology 2021

October 21, 2021 to October 24, 2021

Now Virtual! 


Engage the experts. Get your questions answered.

This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.

In every session, our faculty share any data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, natural medications, combining pharmacologic and psychosocial treatments, and much more.

Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.
 


NOTE:

If you purchased the bundled admission to Women's Mental Health and Psychopharmacology 2021 you must complete the evaluations for both events in order to claim all credit. The Women’s Mental Health course has been pre-loaded into your account. You may access the evaluation and your certificate for that conference at the link below:

lms.mghcme.org/wmhlive2021

Pricing

3-DAY PSYCHOPHARMACOLOGY CONFERENCE

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before July 28, 2021): $549.00
Early Bird Registration (on or before September 4, 2021): $649.00
Regular Registration (after September 4, 2021): $699.00 

Other Professionals or Trainees
Super Early Bird Registration (on or before July 28, 2021): $309.00
Early Bird Registration (on or before September 4, 2021): $409.00 
Regular Registration (after September 4, 2021): $459.00

THURSDAY SESSIONS

Thursday Evening Sessions (October 21): $175
Choose between the following topics:

  • Law and Psychiatry
  • Psychosomatic Medicine/Consultation-Liaison Psychiatry
  • The Neuroscience Revolution: How will it Affect Patient Care?

Women’s Mental Health: $250 
If you are interested in attending the Women's Mental Health session ONLY, you can register for it by clicking here
This is a full day program that precedes the Psychopharmacology program and offers an additional 6.25 of CME/CEU credits.


PSYCHOPHARMACOLOGY AND WOMEN’S MENTAL HEALTH BUNDLED PRICING (SAVINGS OF $55)

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before August 4, 2021) = $744
Early Bird Registration (on or before September 4, 2021) = $849
Regular Registration (after September 4, 2021) = $899

Other Professionals or Trainees 
Super Early Bird Registration (on or before August 4, 2021) = $504
Early Bird Registration (on or before September 4, 2021) = $609
Regular Registration (after September 4, 2021) = $659

 

Syllabus

Price: $48.00
Shipping: $25.00
Total: $73.00

Available for purchase on or before September 24, 2021

The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide. As an alternative to purchasing a conference syllabus, we provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.
 

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 1, 2021.  No refunds will be issued for refund requests made after October 1, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Target Audience

This program is intended for:

Psychiatrists
Psychologists
General and Family Practice Physicians
Psychiatric Nurses
Physician Assistants
Nurse Practitioners
Social Workers

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

  • Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression.
  • Assess obstacles to maintenance of long-term recovery and the liability issues associated with psychopharmacology.
  • Discuss diagnostic and evidenced-based treatment strategies for pediatric onset mood disorders.
  • Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders.
  • Review the course and treatment of psychiatric disorders during pregnancy and menopause.
  • Recognize psychosocial issues and evidence-based treatment modalities for eating and sleep disorders.
  • Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders.
  • Focus on reducing side effects of medication
  • Apply newer strategies in treatment of chemical abuse/dependence
  • Explain more succinctly why to choose a particular medication for a person
  • Explain more clearly how medications affect behaviors and mood
  • Use more evidence-based treatment for psychiatric illness
  • Move to augmentation strategies sooner
  • Screen patients for presence of substance use disorders, especially nicotine and alcohol
  • Renew a collaborative relationship with specialists to begin assisting in performing medication renewals
  • Include newly researched alternatives for augmentation treatment in refractory patients
  • More confidently weigh risks and benefits of treating vs. not continuing treatment during pregnancy
  • Be more cautious associating medications
  • Improve ability to convey to patients the range of treatment options
  • Better evaluate whether medication is needed and consider alternative treatments
  • Institute adjunctive medications that were not thought of previously
  • Follow new algorithms for treatment of bipolar disorder, major depression and schizophrenia
  • Integrate more augmentation strategies and increase use of maintenance ECT
  • Inform patients and colleagues of the most recent state-of-the-art alternatives
  • Take a more substantial sleep history
  • Consider problems that are causing difficulties with cognition, mood, and anxiety
  • Try natural remedies for treatment of depression
  • Educate patients more thoroughly with recent study results
  • Provide patients with more focused and comprehensive discussions regarding and symptom complexes
  • Be more knowledgeable and complete when referring patients
  • Develop a plan to use CBT based techniques
  • Change approaches related to maintenance treatment of bipolar disorder and treatment of mood disorders during pregnancy
  • Thoroughly discuss with patients how current available treatments work and increase medication adherence

Neuroscience Evening Seminar Objectives

  • To distinguish genetic tests that are currently useful in clinical practice from those that may be useful in the future
  • To describe neurotherapeutic techniques that are currently useful and those that may be on the near horizon
  • To delineate roles of neuroimaging in clinical practice versus research
  • To describe the utility of electronic health record (EHR) and other "big data" approaches in developing precision medicine interventions


Psychosomatic Evening Seminar Objectives

  • Identify characteristics of seizures and nonepileptic seizures
  • Identify and analyze electrocardiographic characteristics associated with torsades de pointes
  • Identify predisposing factors for delirium and identify effective treatment regimens to prevent and to reduce agitation and confusion.


Law & Psychiatry Evening Seminar Objectives

  • Identify the most common areas of liability for psychiatrists and mental health practitioners and discuss strategies to manage your risk.
  • Discuss the concept of informed consent and exceptions to this requirement in providing psychiatric care, including involuntary treatment.
  • Identify the elements of medical malpractice and describe strategies for mitigating risk of malpractice claims and judgments.
  • Anticipate potential issues in providing psychiatric care to children of divorcing or divorced parents and identify practice points to reduce your risk.
Course summary
Available credit: 
  • 28.50 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this live activity for a maximum of 28.50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 28.50 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 28.50 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 28.50 Social Workers

    The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

    This program has been approved for 28.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D81571

  • 28.50 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

  • 28.50 Psychologists CE Credit

    The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

    This offering meets the criteria for 28.50 Continuing Education (CE) credits per presentation for psychologists.

Course opens: 
02/28/2021
Course expires: 
11/24/2021
Event starts: 
10/21/2021 - 4:00pm
Event ends: 
10/24/2021 - 5:00pm
Cost:
$772.00
Rating: 
0

Psychopharmacology
OCTOBER 21-24, 2021
Live-Stream

PROGRAM AGENDA

 

THURSDAY, OCTOBER 21, 2021

 

4:00 – 8:00PM            Law and Psychiatry**

THIS IS A TICKETED EVENT

 

4:00 – 8:00PM            Psychosomatic Medicine/ Consultation-Liaison Psychiatry

THIS IS A TICKETED EVENT

 

4:00 – 8:00PM            The Neuroscience Revolution: How will it Affect Patient Care?

THIS IS A TICKETED EVENT

 

FRIDAY, OCTOBER 22, 2021  

 

8:00 – 8:10AM           Welcoming Remarks & Introduction

Maurizio Fava, MD & Jerrold Rosenbaum, MD

 

MODULE TOPIC – MOOD DISORDERS

 

8:10 – 8:55AM           Bipolar Depression

Andrew A. Nierenberg, MD

 

8:55 – 9:40AM           Bipolar Long-Term Management

Roy H. Perlis, MD, MSc

 

9:40 – 9:55AM           Break

 

9:55 – 10:40AM         Treatment Resistant Depression

Maurizio Fava, MD

 

10:40 – 11:20 AM      Panel Discussion

Moderator: Jerrold Rosenbaum, MD

Panelists: Andrew A. Nierenberg, MD, Roy H. Perlis, MD, MSc, Maurizio Fava, MD

 

11:20 – 12:20PM        Lunch Break

 

MODULE TOPIC – ANXIETY/PTSD

 

12:20 – 1:05PM          PTSD

Eric Bui, MD, PhD

 

1:05 – 1:50PM            Anxiety Disorders and Treatments

Jerrold Rosenbaum, MD

 

1:50 – 2:30PM            Panel Discussion

Moderator: Lee Cohen, MD

Panelists: Eric Bui, MD, PhD, Jerrold Rosenbaum, MD, Franklin King, MD

 

2:30 – 2:45PM            Break

 

MODULE TOPIC – WOMEN’S HEALTH

 

2:45 – 3:30PM            Course and Treatment of Mood and Anxiety Disorders During Pregnancy

Lee S. Cohen, MD

 

3:30 – 4:15PM            Postpartum Mood Disorders

Marlene P. Freeman, MD

 

4:15 – 4:55PM            Panel Discussion

Moderator: David H. Rubin, MD

Panelists: Lee S. Cohen, MD, & Marlene P. Freeman, MD

 

4:55 – 5:55 PM           Friday Evening Seminars:

All Friday and Saturday evening seminars will be pre-recorded to allow all attendees to access each session (please pick 2).

            .

Natural Medications for Psychiatric Disorders

David Mischoulon, MD, PhD

 

Suicide

Theodore A. Stern, MD

 

The Neurobiology of Addiction

Jodi Gilman, PhD

 

Psychopharmacology of Sleep Disorders

John W. Winkelman, MD, PhD

 

The Neurobiology of Mood and Psychotic Disorder

Jacqueline Clauss, MD, PhD

 

Exercise Interventions to Augment Psychopharmacology

Michael W. Otto, PhD

 

Stimulation and/or Surgical Approaches to Psychiatric Illness

Joan Camprodon, MD, PhD

 

Psychopharmacology of Autism

Chris McDougle, MD

 

5:55PM                       Adjourn

 

SATURDAY, OCTOBER 23, 2021

 

8:00 – 8:10 AM          Welcoming Remarks & Introduction

David H. Rubin, MD

 

MODULE TOPIC – PSYCHOSIS

 

8:10 – 8:55AM           First-Episode Psychosis and Schizophrenia

Oliver Freudenreich, MD, FACLP

 

8:55 – 9:40AM           Management of Side-Effects of Antipsychotics

Oliver Freudenreich, MD, FACLP

 

9:40 – 9:55AM         Break

 

MODULE TOPIC – KETAMINE & ESKETAMINE

 

9:55 – 10:40AM         Ketamine and Esketamine: From Research to Clinical Practice

Cristina Cusin, MD

 

10:40 – 11:20AM       Panel Discussion

Moderator: David H. Rubin, MD

Panelists: Oliver Freudenreich, MD, FACLP & Cristina Cusin, MD

 

11:20 – 12:20PM        Lunch Break  

 

 

 

MODULE TOPIC – NEW THERAPIES: WHAT IS ON THE HORIZON?

 

12:20 – 1:05PM          Psychedelic Medicine

Franklin King, MD

 

1:05 – 1:50PM            New Treatments for Schizophrenia

Oliver Freudenreich, MD, FACLP

 

1:50 – 2:05PM            Break

 

2:05 – 2:50PM            New Treatments for Mood Disorders

Michael E. Henry, MD & Joan Camprodon, MD, PhD

 

2:50 – 3:35PM            What is New in Addiction?

John F. Kelly, PhD

 

3:35 – 4:15PM            Panel Discussion

Moderator: David H. Rubin, MD

Panelists: Michael E. Henry, MD, John F. Kelly, PhD, Joan Camprodon, MD, PhD

 

4:15 – 5:15PM            Saturday Evening Seminars:

All Friday and Saturday evening seminars will be pre-recorded to allow all attendees to access each session (please pick 2).

           

Violence Risk Assessment in Clinical Practice**

Ronald Schouten, MD, JD, Lieutenant Frederick Cabral

 

Geriatrics

Olivia Okereke, MD

 

Traumatic Brain Injury: A Neuropsychiatric Perspective

Kaloyan S. Tanev, MD

 

Illuminating the Black Box: Antidepressants, Youth and Suicide

David H. Rubin, MD

 

PMDD and Depression During the Menopausal Transition:

New Insights

Laura Fagioli Petrillo, EdM, MD

 

5:15PM                       Adjourn

 

SUNDAY, OCTOBER 24, 2021

 

7:50- 8:00 AM            Welcoming Remarks & Introduction

David H. Rubin, MD

 

MODULE TOPIC – ADDICTION

 

8:00 – 8:45AM           Alcohol and Opiates

Vinod Rao, MD, PhD

 

8:45 – 9:30AM           Tobacco and Cocaine

A. Eden Evins, MD, MPH

 

9:30 – 10:10AM         Panel Discussion

Moderator: David H. Rubin, MD

Panelists: A. Eden Evins, MD, MPH, Vinod Rao, MD, PhD

 

10:10 – 10:25AM       Break

 

MODULE TOPIC – OCD

 

10:25 – 11:10AM       OCD

Michael A. Jenike, MD

 

11:10 – 12:05PM        Obsessive-Compulsive Related Disorders

Lisa M. Zakhary, MD, PhD

 

12:05 – 12:50PM        Cognitive Behavioral Therapy

Sabine Wilhelm, PhD

 

12:50 – 1:30PM          Panel Discussion

Moderator: Michael A. Jenike, MD

Panelists: Lisa M. Zakhary, MD, PhD, Sabine Wilhelm, PhD 

 

 

1:30 – 2:30PM            Lunch Break  

 

MODULE TOPIC – ACROSS THE LIFESPAN

 

2:30 – 3:15PM            Pediatric Bipolar Disorder and Mood Disorders

Janet Wozniak, MD

 

3:15 – 4:00PM            ADHD

Joseph Biederman, MD

 

4:00 – 4:45PM            Drug Interactions

Jonathan E. Alpert, MD, PhD

 

4:45 – 5:25PM            Panel Discussion

Moderator: Joseph Biederman, MD

Panelists: Jonathan E. Alpert, MD, Janet Wozniak, MD

 

5:25PM                       Adjour

Available Credit

  • 28.50 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this live activity for a maximum of 28.50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 28.50 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 28.50 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 28.50 Social Workers

    The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

    This program has been approved for 28.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D81571

  • 28.50 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

  • 28.50 Psychologists CE Credit

    The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

    This offering meets the criteria for 28.50 Continuing Education (CE) credits per presentation for psychologists.

Price

Cost:
$772.00
Please login or register to take this course.

If you are interested in attending the Women's Mental Health session ONLY, you can register for it by clicking here
This is a full day program that precedes the Psychopharmacology program and offers an additional 6.25 of CME/CEU credits.